Neyt M - Search Results

1

A cost-utility analysis of transcatheter aortic valve implantation in Belgium: focusing on a well-defined and identifiable population.

Neyt M, Van Brabandt H, Devriese S, Van De Sande S. Neyt M, et al. BMJ Open. 2012 May 4;2(3):e001032. doi: 10.1136/bmjopen-2012-001032. Print 2012. BMJ Open. 2012. PMID: 22561354 Free PMC article.

2

Cost effectiveness of implantable cardioverter-defibrillators for primary prevention in a Belgian context.

Neyt M, Thiry N, Ramaekers D, Van Brabandt H. Neyt M, et al. Appl Health Econ Health Policy. 2008;6(1):67-80. doi: 10.2165/00148365-200806010-00006. Appl Health Econ Health Policy. 2008. PMID: 18774871

3

Cost-effectiveness analyses of drug eluting stents versus bare metal stents: a systematic review of the literature.

Neyt M, Van Brabandt H, Devriese S, De Laet C. Neyt M, et al. Health Policy. 2009 Jul;91(2):107-20. doi: 10.1016/j.healthpol.2008.11.014. Epub 2009 Jan 9. Health Policy. 2009. PMID: 19135756 Review.

4

What is the evidence in favor of percutaneous aortic valve insertion?

Van Brabandt H, Neyt M. Van Brabandt H, et al. Among authors: neyt m. Am J Cardiol. 2009 Feb 15;103(4):575. doi: 10.1016/j.amjcard.2008.12.003. Am J Cardiol. 2009. PMID: 19195527 No abstract available.

5

Cost-effectiveness of statins in the primary prevention of cardiovascular disease: a systematic review and economic analysis for Belgium.

Neyt M, De Laet C, Van Brabandt H, Franco O, Ramaekers D. Neyt M, et al. Acta Cardiol. 2009 Feb;64(1):1-10. doi: 10.2143/AC.64.1.2034354. Acta Cardiol. 2009. PMID: 19317290 Review.

6

Cost effectiveness of drug-eluting stents in Belgian practice: healthcare payer perspective.

Neyt M, De Laet C, De Ridder A, Van Brabandt H. Neyt M, et al. Pharmacoeconomics. 2009;27(4):313-27. doi: 10.2165/00019053-200927040-00004. Pharmacoeconomics. 2009. PMID: 19485427

7

Percutaneous pulmonary and aortic valve insertion in Belgium: going for conditional reimbursement or waiting for further evidence?

Neyt M, Vinck I, Gewillig M, Van Brabandt H. Neyt M, et al. Int J Technol Assess Health Care. 2009 Jul;25(3):281-9. doi: 10.1017/S0266462309990080. Int J Technol Assess Health Care. 2009. PMID: 19619346 Review.

8

Safety of percutaneous aortic valve insertion. A systematic review.

Van Brabandt H, Neyt M. Van Brabandt H, et al. Among authors: neyt m. BMC Cardiovasc Disord. 2009 Sep 1;9:45. doi: 10.1186/1471-2261-9-45. BMC Cardiovasc Disord. 2009. PMID: 19723312 Free PMC article. Review.

9

Pitfalls in health-economic evaluations: the case of cost-effectiveness of prophylactic implantable cardioverter-defibrillator therapy in Belgium.

Van Brabandt H, Neyt M. Van Brabandt H, et al. Among authors: neyt m. Europace. 2009 Dec;11(12):1571-3. doi: 10.1093/europace/eup290. Epub 2009 Oct 8. Europace. 2009. PMID: 19819879 No abstract available.

10

Tiotropium's cost-effectiveness for the treatment of COPD: a cost-utility analysis under real-world conditions.

Neyt M, Devriese S, Thiry N, Van den Bruel A. Neyt M, et al. BMC Pulm Med. 2010 Sep 15;10:47. doi: 10.1186/1471-2466-10-47. BMC Pulm Med. 2010. PMID: 20843311 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

69 results

Search Page

Filters